 Lisa Spencer
Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 34 | 2024 | 324 | 8.110 |
Why?
| | Enteritis | 6 | 2024 | 93 | 2.110 |
Why?
| | Eosinophilia | 8 | 2024 | 204 | 2.080 |
Why?
| | Gastritis | 5 | 2024 | 96 | 1.950 |
Why?
| | Hypersensitivity | 3 | 2022 | 249 | 1.560 |
Why?
| | Allergens | 4 | 2024 | 385 | 1.520 |
Why?
| | Eosinophilic Esophagitis | 4 | 2024 | 318 | 1.460 |
Why?
| | Intestine, Small | 2 | 2021 | 151 | 1.120 |
Why?
| | Antigen Presentation | 2 | 2018 | 207 | 1.010 |
Why?
| | Receptor, Notch2 | 1 | 2024 | 15 | 0.910 |
Why?
| | Intestines | 3 | 2024 | 350 | 0.880 |
Why?
| | Duodenitis | 1 | 2022 | 7 | 0.800 |
Why?
| | CD11 Antigens | 1 | 2022 | 30 | 0.760 |
Why?
| | Receptors, Notch | 2 | 2015 | 84 | 0.740 |
Why?
| | Signal Transduction | 7 | 2024 | 4935 | 0.740 |
Why?
| | Cytokines | 7 | 2017 | 2022 | 0.670 |
Why?
| | Mucous Membrane | 1 | 2020 | 125 | 0.640 |
Why?
| | Integrins | 1 | 2019 | 94 | 0.610 |
Why?
| | Cell Degranulation | 7 | 2017 | 42 | 0.610 |
Why?
| | Flow Cytometry | 5 | 2021 | 1160 | 0.600 |
Why?
| | Immunity, Innate | 5 | 2017 | 804 | 0.600 |
Why?
| | Th2 Cells | 2 | 2010 | 171 | 0.580 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2015 | 147 | 0.520 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 593 | 0.520 |
Why?
| | Receptors, IgG | 1 | 2016 | 73 | 0.520 |
Why?
| | Environmental Exposure | 1 | 2020 | 463 | 0.500 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 532 | 0.490 |
Why?
| | Immunity, Humoral | 1 | 2016 | 118 | 0.490 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2015 | 30 | 0.470 |
Why?
| | Immunoglobulin E | 1 | 2016 | 330 | 0.460 |
Why?
| | Diet Therapy | 1 | 2015 | 34 | 0.460 |
Why?
| | Diet, Reducing | 1 | 2015 | 87 | 0.450 |
Why?
| | Extracellular Traps | 3 | 2019 | 49 | 0.420 |
Why?
| | Biomarkers | 3 | 2022 | 3971 | 0.420 |
Why?
| | Secretory Vesicles | 5 | 2016 | 24 | 0.420 |
Why?
| | Mice | 11 | 2024 | 16983 | 0.390 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 392 | 0.390 |
Why?
| | Animals | 19 | 2024 | 35409 | 0.380 |
Why?
| | Postpartum Period | 1 | 2015 | 331 | 0.370 |
Why?
| | Organ Specificity | 3 | 2020 | 295 | 0.370 |
Why?
| | Interleukin-4 | 3 | 2008 | 212 | 0.360 |
Why?
| | Chemokine CCL11 | 6 | 2016 | 26 | 0.350 |
Why?
| | Phenotype | 2 | 2022 | 3062 | 0.340 |
Why?
| | Cytoplasmic Granules | 5 | 2017 | 78 | 0.310 |
Why?
| | Inflammation | 5 | 2022 | 2748 | 0.310 |
Why?
| | Autocrine Communication | 1 | 2009 | 42 | 0.310 |
Why?
| | Galectins | 2 | 2019 | 22 | 0.310 |
Why?
| | Mice, Inbred C57BL | 5 | 2024 | 5468 | 0.300 |
Why?
| | Immunophenotyping | 3 | 2020 | 310 | 0.290 |
Why?
| | Th1 Cells | 1 | 2008 | 137 | 0.280 |
Why?
| | Leukocytes | 2 | 2021 | 306 | 0.280 |
Why?
| | Asthma | 1 | 2021 | 2225 | 0.280 |
Why?
| | Humans | 37 | 2024 | 129847 | 0.270 |
Why?
| | Ligands | 1 | 2009 | 621 | 0.260 |
Why?
| | Cell Differentiation | 3 | 2015 | 1900 | 0.260 |
Why?
| | Receptors, Cytokine | 1 | 2006 | 35 | 0.250 |
Why?
| | Homeostasis | 2 | 2021 | 605 | 0.240 |
Why?
| | Mice, Knockout | 3 | 2024 | 2888 | 0.240 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2135 | 0.220 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1205 | 0.210 |
Why?
| | Bile Acids and Salts | 1 | 2024 | 195 | 0.210 |
Why?
| | Cells, Cultured | 7 | 2016 | 4102 | 0.210 |
Why?
| | Allergy and Immunology | 2 | 2024 | 42 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 836 | 0.190 |
Why?
| | Rare Diseases | 2 | 2024 | 96 | 0.190 |
Why?
| | Crystallization | 2 | 2019 | 137 | 0.190 |
Why?
| | CD11c Antigen | 1 | 2022 | 41 | 0.190 |
Why?
| | Food Hypersensitivity | 1 | 2024 | 177 | 0.180 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 521 | 0.170 |
Why?
| | Leukocyte Count | 1 | 2021 | 326 | 0.170 |
Why?
| | Tetraspanin 30 | 3 | 2016 | 10 | 0.160 |
Why?
| | Cell Separation | 1 | 2021 | 316 | 0.160 |
Why?
| | Mice, Inbred BALB C | 4 | 2016 | 1248 | 0.160 |
Why?
| | Cell Death | 2 | 2018 | 353 | 0.150 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 205 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 334 | 0.150 |
Why?
| | Exocytosis | 2 | 2016 | 88 | 0.150 |
Why?
| | Immunoglobulin G | 1 | 2022 | 851 | 0.150 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 14 | 0.140 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 151 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4077 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 377 | 0.130 |
Why?
| | Eosinophil Granule Proteins | 2 | 2007 | 21 | 0.130 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1092 | 0.130 |
Why?
| | Advisory Committees | 1 | 2018 | 216 | 0.130 |
Why?
| | Ovalbumin | 1 | 2016 | 178 | 0.130 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 263 | 0.130 |
Why?
| | Antigens | 2 | 2016 | 356 | 0.120 |
Why?
| | Microscopy, Electron, Transmission | 6 | 2015 | 146 | 0.120 |
Why?
| | Gastroenterology | 1 | 2018 | 177 | 0.120 |
Why?
| | Adaptive Immunity | 1 | 2016 | 161 | 0.120 |
Why?
| | Receptor, Notch1 | 1 | 2015 | 62 | 0.120 |
Why?
| | Eosinophil Major Basic Protein | 3 | 2009 | 7 | 0.110 |
Why?
| | Respiratory Hypersensitivity | 1 | 2015 | 65 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 376 | 0.110 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 206 | 0.110 |
Why?
| | Anti-HIV Agents | 1 | 2021 | 757 | 0.110 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2015 | 80 | 0.110 |
Why?
| | Adoptive Transfer | 1 | 2015 | 218 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2017 | 505 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2545 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2019 | 756 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2017 | 401 | 0.110 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 314 | 0.100 |
Why?
| | Machine Learning | 1 | 2017 | 441 | 0.100 |
Why?
| | Microscopy, Immunoelectron | 3 | 2009 | 42 | 0.100 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 220 | 0.100 |
Why?
| | Protein Transport | 3 | 2016 | 429 | 0.100 |
Why?
| | Life Style | 1 | 2015 | 462 | 0.100 |
Why?
| | Ribonucleases | 1 | 2012 | 54 | 0.100 |
Why?
| | Detergents | 1 | 2011 | 44 | 0.090 |
Why?
| | Chemokines, CC | 3 | 2006 | 33 | 0.090 |
Why?
| | Cytoplasm | 2 | 2016 | 269 | 0.090 |
Why?
| | Body Weight | 1 | 2015 | 947 | 0.090 |
Why?
| | Health | 1 | 2010 | 75 | 0.080 |
Why?
| | Algorithms | 1 | 2017 | 1617 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2703 | 0.080 |
Why?
| | Helminths | 1 | 2010 | 7 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1465 | 0.080 |
Why?
| | Helminthiasis | 1 | 2010 | 11 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 494 | 0.080 |
Why?
| | Disease | 1 | 2010 | 94 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2011 | 363 | 0.080 |
Why?
| | Centrifugation, Density Gradient | 1 | 2009 | 39 | 0.080 |
Why?
| | Receptors, Immunologic | 1 | 2010 | 216 | 0.080 |
Why?
| | Cell Fractionation | 1 | 2009 | 56 | 0.080 |
Why?
| | Jagged-2 Protein | 1 | 2009 | 1 | 0.080 |
Why?
| | Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| | Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1368 | 0.080 |
Why?
| | Hypereosinophilic Syndrome | 2 | 2024 | 10 | 0.080 |
Why?
| | Endopeptidases | 1 | 2009 | 85 | 0.080 |
Why?
| | Receptors, Chemokine | 2 | 2006 | 45 | 0.070 |
Why?
| | Organelles | 1 | 2008 | 54 | 0.070 |
Why?
| | Interferon-gamma | 2 | 2008 | 773 | 0.070 |
Why?
| | Incidence | 1 | 2015 | 2646 | 0.070 |
Why?
| | Peptide Hydrolases | 1 | 2009 | 108 | 0.070 |
Why?
| | Immunity, Cellular | 1 | 2010 | 265 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1441 | 0.070 |
Why?
| | Interleukin-13 | 1 | 2008 | 147 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 213 | 0.070 |
Why?
| | Female | 5 | 2021 | 68829 | 0.070 |
Why?
| | Transcription Factors | 1 | 2015 | 1645 | 0.070 |
Why?
| | Lung | 1 | 2020 | 3940 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 373 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2730 | 0.060 |
Why?
| | Receptors, Interleukin-4 | 1 | 2006 | 15 | 0.060 |
Why?
| | Receptors, CCR3 | 1 | 2006 | 8 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 1 | 2006 | 37 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1406 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 443 | 0.060 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2008 | 373 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1086 | 0.060 |
Why?
| | Intracellular Membranes | 1 | 2005 | 83 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 827 | 0.060 |
Why?
| | Avidin | 1 | 2005 | 2 | 0.060 |
Why?
| | Child | 2 | 2022 | 20962 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2022 | 14553 | 0.060 |
Why?
| | Sepharose | 1 | 2005 | 33 | 0.060 |
Why?
| | Gels | 1 | 2005 | 83 | 0.060 |
Why?
| | Ileitis | 1 | 2024 | 32 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2005 | 143 | 0.060 |
Why?
| | Biological Therapy | 1 | 2024 | 28 | 0.060 |
Why?
| | Cholangitis, Sclerosing | 1 | 2024 | 71 | 0.050 |
Why?
| | Ileum | 1 | 2024 | 116 | 0.050 |
Why?
| | Exercise | 1 | 2015 | 1934 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2024 | 216 | 0.050 |
Why?
| | Antibodies | 1 | 2005 | 399 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1119 | 0.050 |
Why?
| | Brugia pahangi | 1 | 2002 | 1 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2024 | 281 | 0.050 |
Why?
| | Brugia malayi | 1 | 2002 | 2 | 0.050 |
Why?
| | Filariasis | 1 | 2002 | 3 | 0.050 |
Why?
| | Peritoneal Cavity | 1 | 2002 | 31 | 0.050 |
Why?
| | Cell Membrane | 2 | 2018 | 734 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 6423 | 0.050 |
Why?
| | Langerhans Cells | 1 | 2001 | 11 | 0.050 |
Why?
| | Dermis | 1 | 2001 | 31 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2885 | 0.050 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2001 | 86 | 0.050 |
Why?
| | Biological Transport | 2 | 2016 | 405 | 0.040 |
Why?
| | United States | 3 | 2024 | 13913 | 0.040 |
Why?
| | Emtricitabine | 1 | 2021 | 168 | 0.040 |
Why?
| | Protein Binding | 1 | 2006 | 2123 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 122 | 0.030 |
Why?
| | Platelet Membrane Glycoproteins | 2 | 2009 | 36 | 0.030 |
Why?
| | Brefeldin A | 2 | 2008 | 10 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1690 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 271 | 0.030 |
Why?
| | Skin | 1 | 2001 | 725 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2017 | 284 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 334 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1839 | 0.030 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2015 | 10 | 0.030 |
Why?
| | X-Box Binding Protein 1 | 1 | 2015 | 9 | 0.030 |
Why?
| | Granulocyte Precursor Cells | 1 | 2015 | 9 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 658 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2015 | 72 | 0.030 |
Why?
| | Antigens, CD | 2 | 2009 | 487 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 101 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 318 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 954 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1847 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2015 | 697 | 0.020 |
Why?
| | Extracellular Space | 1 | 2013 | 120 | 0.020 |
Why?
| | Adult | 1 | 2015 | 35634 | 0.020 |
Why?
| | Cell-Free System | 1 | 2012 | 48 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 71 | 0.020 |
Why?
| | Registries | 1 | 2017 | 1903 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2009 | 78 | 0.020 |
Why?
| | Triiodobenzoic Acids | 1 | 2009 | 9 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2009 | 80 | 0.020 |
Why?
| | Proteoglycans | 1 | 2009 | 109 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1686 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2016 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 2007 | 52 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 399 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 245 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2007 | 425 | 0.020 |
Why?
| | Male | 3 | 2024 | 63759 | 0.020 |
Why?
| | Chemokines | 1 | 2007 | 227 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1204 | 0.020 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2005 | 7 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1311 | 0.020 |
Why?
| | Forecasting | 1 | 2007 | 361 | 0.020 |
Why?
| | Chemokine CCL5 | 1 | 2005 | 43 | 0.020 |
Why?
| | Platelet Activating Factor | 1 | 2005 | 75 | 0.020 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2005 | 41 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2011 | 1058 | 0.010 |
Why?
| | Infant | 1 | 2017 | 9018 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 10522 | 0.010 |
Why?
| | Molting | 1 | 2002 | 9 | 0.010 |
Why?
| | Immunocompetence | 1 | 2002 | 42 | 0.010 |
Why?
| | Chemokine CCL20 | 1 | 2001 | 5 | 0.010 |
Why?
| | Receptors, CCR6 | 1 | 2001 | 4 | 0.010 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2001 | 11 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2005 | 530 | 0.010 |
Why?
| | Granuloma | 1 | 2002 | 90 | 0.010 |
Why?
| | Mice, SCID | 1 | 2002 | 350 | 0.010 |
Why?
| | Chemotaxis | 1 | 2001 | 130 | 0.010 |
Why?
| | Endocytosis | 1 | 2001 | 162 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1724 | 0.010 |
Why?
| | Lymphocytes | 1 | 2002 | 377 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 790 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 20451 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1645 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2001 | 1110 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 578 | 0.010 |
Why?
| | Macrophages | 1 | 2002 | 1489 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|